Each person’s unique genetic makeup can lead to different medication side effects and effectiveness. This article will delve into some information about this topic and address how it will shape the future of medicine.
Pharmacogenomics
Pharmacogenomics is a branch of science that mixes both pharmacology and genomics. Pharmacology can be thought of as the study of drugs, including how they affect people. On the other side, genomics takes a look at how genetic makeup can cause medicines to behave in a variety of ways in different people.
The researchers in this field work to come up with ways to make medications that work more effectively according to each individual’s genetic makeup. It can even save lives. This is because some unfortunate patients can end up having bad reactions to certain drugs, which can then lead to death.
It’s no secret that this branch of science will undoubtedly shape the future of how medications are created and administered. Not only is it a topic of the future, though; it is also being utilized in the present.
Its Use Today
The use of pharmacogenomics is currently underway in the creation of new drugs for cancer and AIDS patients. Some of the medications to come will most likely be required to undergo genetic testing before being approved for administration, with the goal of keeping patients safer and providing more effective treatment.
There is a research undertaking called the Human Genome Project. This project aims to map the whole human genome. It is a very exciting endeavor as it will most certainly improve how well scientists can create new drugs based on a person’s genetics, reducing negative side effects and becoming more effective.
This will eventually lead to specific medications or particular dosage amounts or instructions based on a patient’s specific genes. In fact, the Human Genome Project has already led to a great deal of progress in the understanding of how certain genes can affect the way medications work in an individual. There is still an unbelievable amount left to learn, however.